X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.contractpharma.com/contents/view_breaking-news/2023-01-23/cytoreason-licenses-ibd-disease-model-to-sanofi-in-expanded-alliance/?widget=listSection
https://www.fiercebiotech.com/medtech/cytoreason-pfizer-ink-110m-five-year-extension-ai-powered-drug-development-deal
https://www.globenewswire.com/news-release/2022/09/20/2519131/0/en/CytoReason-Announces-Expanded-Collaboration-Deal-with-Pfizer-to-Deliver-AI-for-Drug-Discovery-and-Development.html
https://www.contractpharma.com/contents/view_breaking-news/2022-09-20/cytoreason-extends-multi-year-partnership-with-pfizer/
https://www.biospectrumasia.com/news/26/20077/cytoreason-expands-reach-in-asia-leveraging-ml-in-drug-development-for-korean-drugmakers-.html
https://www.prnewswire.com/news-releases/cytoreason-expands-its-reach-in-asia-forging-commercial-alliance-with-helixrus-to-leverage-machine-learning-in-drug-development-for-korean-drugmakers-301523552.html
https://www.australianjewishnews.com/pfizer-extends-deal-with-israeli-ai-firm/
https://www.fiercebiotech.com/medtech/pfizer-re-ups-cytoreason-collab-applying-ai-disease-models-to-drug-development
Market Place
Share 
